Significance of bulky mass and residual tumor —Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients

In this study, it appears that performing iPET is the most convincing method in improving evaluation and i n finding patients with increased risk of relapse. Evidently, patients with negative iPET will not benefit from including RT in the treatment after metabolic complete response (CR), and patients with primary refractory disease are most likely in the group of positive iPET.

Source: Cancer Medicine - January 21, 2020 Category: Cancer & Oncology Authors: Susanna Tokola, Hanne Kuitunen, Taina Turpeenniemi ‐Hujanen, Outi Kuittinen Tags: ORIGINAL RESEARCH Source Type: research